UnitedHealth Group Incorporated
NYSE:UNHMedical - Healthcare Plans
+$3.69 today
- Market cap
- $313.53B
- Beta
- 0.65
- P/E (TTM)
- 30.5
- EPS (TTM)
- $13.24
- Dividend yield
- 2.22%
Volume 17.34M
Average 8.23M
UNH EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
UnitedHealth Group IncorporatedNYSE: UNH
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $7.56B rose 41.8% year over year, ahead of the -8.3% change in trailing-twelve-month EBITDA. Sequentially, it fell 15.7% from the prior quarter. Over 3 fiscal years it compounded at -10.2% a year.
Context
- EBITDA amounted to 5.2% of revenue in FY2025, down 1.9 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 17 analysts of $32.48B (+40.8%) for the fiscal year ending Dec 2026, a step up from the -17.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $7.56B-15.7% QoQ
- Last fiscal yearDec 2025
- $23.06B-17.9% YoY
- LTMSep 2026
- $27.99B-8.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +41.8% | +242.8% | +201.0 pp |
| 1 year | -17.9% | +40.8% | +58.7 pp |
| 3-year CAGR | -10.2% | +19.2% | +29.4 pp |
| 5-year CAGR | +16.4% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 23.06B USD
- Year-over-year change
- -17.9%
- 4-year CAGR
- -3.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.06B | -17.9% |
| FY2024 | 2024-12-31 | 28.08B | -22.7% |
| FY2023 | 2023-12-31 | 36.33B | +14.1% |
| FY2022 | 2022-12-31 | 31.84B | +17.6% |
| FY2021 | 2021-12-31 | 27.07B | — |
EBITDA vs competitors
How UNH compares with its peers on the latest reported figures
- UNH's LTM Sep 2026 EBITDA of $27.99B is the highest of the 9 companies compared; the peer median is $1.94B.
- Its year-over-year change of -8.3% is the 6th highest of 9, against a peer median of -2.1%.
- EBITDA amounts to 6.2% of revenue for UNH, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $27.99B | -8.3% | -10.2% | 6.2% | |
| LTM Jun 2026 | $13.41B | -5.4% | -7.2% | 3.2% | |
| LTM Sep 2026 | $12.53B | +1.2% | +0.7% | 4.4% | |
| LTM Sep 2026 | $8.88B | -11.4% | -1.6% | 4.4% | |
| LTM Sep 2026 | $3.24B | +4.5% | -15.4% | 2.1% | |
| LTM Jun 2026 | $633.7M | +751.9% | — | 4.1% | |
| LTM Sep 2026 | $333M | -78.1% | -10.2% | 0.8% | |
| LTM Mar 2026 | $66.42M | +265.7% | — | 1.6% | |
| LTM Jun 2026 | -$2.73B | -158.1% | — | 1.4% | |
| Peer median (excluding UNH) | $1.94B | -2.1% | -7.2% | 2.7% | |
Competitors are the stored peer set for UNH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 287.6B | 324.16B | 371.62B | 400.28B | 447.57B |
| Cost of Revenue | 217.95B | 244.55B | 280.66B | 310.88B | 364.65B |
| Gross Profit | 69.65B | 79.62B | 90.96B | 89.4B | 82.92B |
| Gross Margin | 24.2% | 24.6% | 24.5% | 22.3% | 18.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 45.68B | 51.18B | 58.6B | 57.11B | 63.95B |
| Depreciation & Amortization | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B |
| EBITDA | 27.07B | 31.84B | 36.33B | 28.08B | 23.06B |
| EBITDA Margin | 9.4% | 9.8% | 9.8% | 7.0% | 5.2% |
| Operating Income | 23.97B | 28.44B | 32.36B | 32.29B | 18.96B |
| Operating Margin | 8.3% | 8.8% | 8.7% | 8.1% | 4.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.66B | 2.09B | 3.25B | 3.91B | 4B |
| Other Income / Expenses | (1.66B) | (2.09B) | (3.25B) | (12.22B) | (4.27B) |
| Income Before Tax | 22.31B | 26.34B | 29.11B | 20.07B | 14.7B |
| Pre-Tax Margin | 7.8% | 8.1% | 7.8% | 5.0% | 3.3% |
| Income Tax Expense | 4.58B | 5.7B | 5.97B | 4.83B | 1.89B |
| Net Income | 17.29B | 20.12B | 22.38B | 14.41B | 12.06B |
| Net Margin | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% |
| EPS (Basic) | 18.33 | 21.54 | 24.12 | 15.64 | 13.23 |
| EPS (Diluted) | 18.08 | 21.18 | 23.86 | 15.51 | 13.23 |
| Weighted Avg Shares | 943M | 934M | 928M | 929M | 910M |
| Weighted Avg Shares (Diluted) | 956M | 950M | 938M | 929M | 910M |
UnitedHealth Group Incorporated
NYSE:UNH
Intrinsic Alpha fair value
Locked
Current Price
$349.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.